Letter to the Editor/Reply
The Use of the Chronic Kidney Disease Epidemiology Collaboration Equation and Global Cardiovascular Risk Assessment in Patients with Atrial FibrillationProvidência R.a, b · Barra S.a · Paiva L.a · Faustino A.a
aCardiology Department, Coimbra's Hospital Centre and University and bUniversity of Coimbra, Faculty of Medicine, Coimbra, Portugal
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
No abstract available
- Balta S, Demirkol S, Arslan Z, Sahin MA, Yesil FG, Kucuk U: The relation between decreased glomerular filtration rate and nonvalvular atrial fibrillation. Cardiology 2013;124:219.
- Providência R, Fernandes A, Paiva L, Faustino A, Barra S, Botelho A, et al: Decreased glomerular filtration rate and markers of left atrial stasis in patients with non-valvular atrial fibrillation. Cardiology 2013;124:3-10.
- Michels WM, Grootendorst DC, Verduijn M, Elliott EG, Dekker FW, Krediet RT: Performance of the Cockcroft-Gault, MDRD, and new CKD-EPI formulas in relation to GFR, age, and body size. Clin J Am Soc Nephrol 2010;5:1003-1009.
Lee M, Saver JL, Chang KH, Liao HW, Chang SC, Ovbiagele B: Low glomerular filtration rate and risk of stroke: meta-analysis. BMJ 2010;34:c4249.
- Go AS, Fang MC, Udaltsova N, Chang Y, Pomernacki NK, Borowsky L, et al: Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Circulation 2009;119:1363-1369.
- Matsushita K, Tonelli M, Lloyd A, Levey AS, Coresh J, Hemmelgarn BR, et al: Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) study equation for estimated GFR. Am J Kidney Dis 2012;60:241-249.
- Piccini JP, Stevens SR, Chang Y, Singer DE, Lokhnygina Y, Go AS, et al: Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF and ATRIA study cohorts. Circulation 2013;127:224-232.
- Olesen JB, Lip GY, Kamper AL, Hommel K, Køber L, Lane DA, et al: Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med 2012;367:625-635.
- Lopez FL, Agarwal SK, Grams ME, Loehr LR, Soliman EZ, Lutsey PL, et al: Relation of serum phosphorus levels to the incidence of atrial fibrillation [from the Atherosclerosis Risk in Communities (ARIC) Study]. Am J Cardiol 2013;111:857-862.
- Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, et al: European guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2012;33:1635-1701.
- Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, et al: 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Association. Europace 2012;14:1385-1413.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.